Picotamide inhibition of excess in vitro thromboxane B-2 release by colorectal mucosa in inflammatory bowel disease

被引:16
作者
Collins, CE [1 ]
Benson, MJ [1 ]
Burnham, WR [1 ]
Rampton, DS [1 ]
机构
[1] OLDCHURCH HOSP,DEPT GASTROENTEROL,ROMFORD RM7 0BE,ESSEX,ENGLAND
关键词
D O I
10.1111/j.0953-0673.1996.00315.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A(2) has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. Methods: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B-2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. Results: Increased amounts of thromboxane B-2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147-325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61-140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64-206), 8). Incubation with picotamide at concentrations between 100 mu M and 1 mM reduced thromboxane B-2 release (IC50 890 mu M). Conclusion: Since increased thromboxane A(2) production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 33 条
[1]   EFFECT OF PICOTAMIDE ON THE CLINICAL PROGRESSION OF PERIPHERAL VASCULAR-DISEASE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY [J].
BALSANO, F ;
VIOLI, F .
CIRCULATION, 1993, 87 (05) :1563-1569
[2]   VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J].
BARON, JH ;
CONNELL, AM ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1964, 1 (5374) :89-+
[3]   RELATIONSHIP BETWEEN PAF-ACETHER AND THROMBOXANE-A2 BIOSYNTHESIS IN ENDOTOXIN-INDUCED INTESTINAL DAMAGE IN THE RAT [J].
BOUGHTONSMITH, NK ;
HUTCHESON, I ;
WHITTLE, BJR .
PROSTAGLANDINS, 1989, 38 (03) :319-333
[4]  
CASELLAS F, 1995, EUR J GASTROEN HEPAT, V7, P221
[5]  
COLLINS CE, 1995, GASTROENTEROLOGY, V108, pA799
[6]   PLATELETS CIRCULATE IN AN ACTIVATED STATE IN INFLAMMATORY BOWEL-DISEASE [J].
COLLINS, CE ;
CAHILL, MR ;
NEWLAND, AC ;
RAMPTON, DS .
GASTROENTEROLOGY, 1994, 106 (04) :840-845
[7]  
DOUKAS J, 1988, BLOOD, V71, P771
[8]  
GERTNER DJ, 1992, ALIMENT PHARM THERAP, V6, P163
[9]   THROMBOXANE-A2 INDUCES LEUKOTRIENE-B4 SYNTHESIS THAT IN TURN MEDIATES NEUTROPHIL DIAPEDESIS VIA CD-18 ACTIVATION [J].
GOLDMAN, G ;
WELBOURN, R ;
VALERI, CR ;
SHEPRO, D ;
HECHTMAN, HB .
MICROVASCULAR RESEARCH, 1991, 41 (03) :367-375
[10]   THROMBOXANE MEDIATES DIAPEDESIS AFTER ISCHEMIA BY ACTIVATION OF NEUTROPHIL ADHESION RECEPTORS INTERACTING WITH BASALLY EXPRESSED INTERCELLULAR-ADHESION MOLECULE .1. [J].
GOLDMAN, G ;
WELBOURN, R ;
KLAUSNER, JM ;
VALERI, CR ;
SHEPRO, D ;
HECHTMAN, HB .
CIRCULATION RESEARCH, 1991, 68 (04) :1013-1019